Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial. Medscape Medical News
Author: Medscape
Trabeculectomy Often More Cost-Effective Than Tube Shunts
Analysis of data from a randomized trial finds trabeculectomy typically is the better financial bet than tube shunt surgery as a first option to treat glaucoma. Medscape Medical News
Are Visual Deficits After Stroke Being Missed?
The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect up to three quarters of survivors. Medscape News Europe
Endophthalmitis a Risk for Years After Tube Shunt Surgery
The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a device-placement surgery for detached retina, a study finds. Medscape Medical News
Does This ED Drug Harm the Retina?
The use of sildenafil is associated with an increased risk for serous retinal detachment in men with erectile dysfunction, a study finds. Medscape Medical News
Study Backs Longer Compounded Lido Plus Epi Shelf Life
Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and up to 7 days with refrigeration. Medscape Medical News
PET/CT Can Catch Cranial GCA Missed by Doppler Ultrasound
Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack of trunk large-vessel involvement. Medscape Medical News
Dry Eye Disease May Occur Years Before Autoimmune Disease
Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears about 3 years before diagnosis, a study finds. Medscape Medical News
AGS 2026
Read clinically focused news coverage of key developments from AGS 2026 Medscape Ophthalmology
Diabetic Retinopathy Severity Tied to Rising Dementia Risk
Greater severity of diabetic retinopathy is associated with a stepwise increase in the risk for all-cause and vascular dementia in patients with type 2 diabetes. Medscape Medical News
Early Retinal Fluid Drying May Extend Injection Gaps in AMD
Rapid drying of retinal fluid with faricimab injections may help identify patients with neovascular age-related macular degeneration who can safely extend time between injections. Medscape Medical News
Ocular Therapeutix Plunges as Modest Benefit Overshadow Trial Win Over Regeneron’s Eylea
Ocular Therapeutix’s experimental eye drug showed superiority to Regeneron’s Eylea in a key late-stage trial, but its modest advantage and higher rates of certain side… Reuters Health Information
Ocular Therapeutix’s Eye Drug Superior to Regeneron’s Eylea in Late-stage Trial
Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron’s approved treatment… Reuters Health Information
New Rx Option for Neuromyelitis Optica Spectrum Disorder?
Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder. Medscape Medical News
Metabolic Syndrome Tied to Glaucoma Risk
Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening. Medscape Medical News
Two Biologics Show Comparable Benefit in Uveitis
Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis. Medscape Medical News
Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis
In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease. Medscape Medical News
Worsening Heart-Kidney-Metabolic Health May Threaten Vision
People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration. Medscape Medical News
PRAME TCR Therapy Delivers Breakthrough in Uveal Melanoma
Dr Teresa Amaral reviews ESMO 2025 data showing unprecedented response rates with PRAME-directed TCR therapy in metastatic uveal melanoma. Medscape Oncology
Mary Tyler Moore Initiative Combats Diabetic Retinal Disease
Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate treatment. Medscape Medical News